LINKÖPING, Sweden, Oct. 30, 2019 /PRNewswire/ -- AMRA Medical has entered into an agreement to support the Dallas Hearts and Minds Study with its Body Composition Profile (BCP) measurements which are focused on muscle and fat. The measurements, derived from magnetic resonance imaging (MRI), will be used to perform next generation phenotyping on the study popula

MINNEAPOLIS, Oct. 30, 2019 /PRNewswire/ -- Vireo Health International, Inc., ("Vireo" or the "Company") (CSNX: VREO; OTQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company, today announced the launch of its new and innovative Green Goods™ retail dispensary brand.

DOVER, Mass., Oct. 30, 2019 /PRNewswire/ -- Backpack Health, a free mobile and web-based multilingual digital platform giving consumers control of their health data with continuous and sha

SEATTLE, Oct. 30, 2019 /PRNewswire/ -- RareCyte announces the launch of a new RarePlex® Staining Kit, enabling customers to evaluate prostate cancer specific expression of ARv7 on circulating tumor cells (CTC) in their own laboratory. ARv7 is the result of a splice variant of Androgen Receptor (AR), a diagnostic prostate cancer biomarker, and ARv7 is assoc

NEW YORK and SHANGHAI, Oct. 30, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the thi

DAVIS, Calif., Oct. 30, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of c

SOUTH SAN FRANCISCO, Calif. and TAMPA, Fla., Oct. 30, 2019 /PRNewswire/ -- Shriners Hospitals for Children is teaming up with Genome Medical to ensure that pediatric patients and families receiving next generation DNA sequencing through the new Genomics Institute at Shriners Hospitals will have access to the highest standard of

CUPERTINO, Calif., Oct. 30, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report third quarter and nine months ended September 30, 2019 financial results and host a conference call after the market close on Monday, November 4, 2019.

HOLLISTON, Mass., Oct. 30, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, today announced

WALTHAM, Mass., Oct. 30, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, has launched